The Association of the British Pharmaceutical Industry (ABPI) applauds the targeting of the Government's extra £100 million research and development funding per year by 2008 on research into the treatment and cure of Alzheimer's, stroke, diabetes and mental health, as well as developing new medicines for children.
24 Mar 2004 Posted in News Release By Press Office
"This is excellent news for clinical research in general as well as these priority disease areas," said Director General Dr Trevor Jones.
He also welcomed the creation of the UK Clinical Research Collaboration (UKCRC), which will bring together the NHS, Medical Research Council, medical charities and industry to speed up the development of new medicines and treatments.
"This investment in collaboration and partnership means more patients will benefit from the latest scientific and medical advances, and will give more patients the opportunity to participate in clinical trials," said Dr Jones.
The extra funding will be used to:
For further information, please contact: ABPI Press Office 020 7747 1410